Myostatin concentration is unreliable as a biomarker of disease progression in dysferlinopathy Moore, U., Simon, E., Day, J., Jones, K., Bharucha-Goebel, D., Pestronk, A., Walter, M., Paradas, C., Stojkovic, T., Bravver, E., Pegoraro, E., Mendell, J., Guglieri, M., Straub, V., Diaz-Manera, J. PERGAMON-ELSEVIER SCIENCE LTD. 2022: S113

View details for DOI 10.1016/j.nmd.2022.07.295

View details for Web of Science ID 000873062200291